ClinicalTrials.Veeva

Menu

Standardized Resistance Training Program and Assessment System for Prostate Cancer Patients Receiving Androgen Deprivation Therapy ISPoRT-PCa-ADT Study Protocol for a Randomized Controlled Trial. SPORT-MU

F

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

Status

Not yet enrolling

Conditions

Prostate Cancer

Treatments

Procedure: Exercise Intervention Protocol
Procedure: SPoRT-Control Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT07064811
SPORT-MU

Details and patient eligibility

About

This randomized controlled trial (RCT) with two parallel study arms evaluated the effectiveness of a 24-week exercise intervention in prostate cancer (PCa) patients under-going androgen deprivation therapy (ADT). Ethical approval was obtained from the Clinical Research Ethics Committee of the University Clinical Hospital "Virgen de la Arrixaca" (Murcia, Spain). Participants were randomly assigned to one of two groups: (1) a supervised progressive resistance training program (SPoRT-PCa-ADT), or (2) a control group receiving a home-based exercise protocol following an initial assessment, accom-panied by weekly telephone follow-up. Assessments were conducted at baseline and at 24 weeks to examine changes in physical, functional, and psychosocial outcomes. Addi-tionally, patient-reported outcomes were collected at the 12-week midpoint (Figure 1). This study design enabled the evaluation of both immediate and sustained intervention effects and facilitated a direct comparison between supervised and home-based exercise approaches

Full description

This randomized controlled trial (RCT) with two parallel study arms evaluated the effectiveness of a 24-week exercise intervention in prostate cancer (PCa) patients under-going androgen deprivation therapy (ADT). Ethical approval was obtained from the Clinical Research Ethics Committee of the University Clinical Hospital "Virgen de la Arrixaca" (Murcia, Spain). Participants were randomly assigned to one of two groups: (1) a supervised progressive resistance training program (SPoRT-PCa-ADT), or (2) a control group receiving a home-based exercise protocol following an initial assessment, accom-panied by weekly telephone follow-up. Assessments were conducted at baseline and at 24 weeks to examine changes in physical, functional, and psychosocial outcomes. Addi-tionally, patient-reported outcomes were collected at the 12-week midpoint (Figure 1). This study design enabled the evaluation of both immediate and sustained intervention effects and facilitated a direct comparison between supervised and home-based exercise approaches

Enrollment

60 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosis of locally advanced or metastatic prostate neoplasm and current treatment with androgen deprivation therapy (ADT)
  • treatment at the radiotherapy oncology department of University Clinical Hospital "Virgen de la Arrixaca"
  • legal adult age with signed informed consent

Exclusion criteria

  • unwillingness to participate in the study
  • inability to complete adequate follow-up due to any cause that would prevent knowledge of patient evolution during the follow-up period
  • no controlled or symptomatic metastatic bone disease
  • physical disabilities that would prevent participants from safely completing the exercise protocol

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

SPORT Protocol intervention
Experimental group
Description:
24 week velocity based resistance training. Twice weekly supervised sessions
Treatment:
Procedure: SPoRT-Control Intervention
SPORT Control intervention
Active Comparator group
Description:
24-week home based resistance training program .
Treatment:
Procedure: Exercise Intervention Protocol

Trial contacts and locations

1

Loading...

Central trial contact

Enrique Cao Avellaneda, MD; Alejandro Soler López

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems